Recent Finacing
Recent Raise
ALA Diagnostics develops a blood-based in vitro diagnostic kit for early multiple sclerosis using a recombinant protein biomarker validated in 598 human samples, advancing clinical trials and Madrid production.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor